$89.5 Million is the total value of FARLEY CAPITAL L.P.'s 14 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 33.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ATGE | ADTALEM GLOBAL ED INC | $47,278,000 | -5.5% | 1,318,776 | 0.0% | 52.84% | -7.0% | |
MA | MASTERCARD INCcl a | $24,389,000 | +16.3% | 172,726 | 0.0% | 27.26% | +14.5% | |
GOOG | ALPHABET INCcap stk cl c | $7,463,000 | +5.5% | 7,781 | 0.0% | 8.34% | +3.9% | |
VRX | VALEANT PHARMACEUTICALS INTL | $3,900,000 | -17.2% | 272,148 | 0.0% | 4.36% | -18.4% | |
CTRP | CTRIP COM INTL LTD | $2,114,000 | -2.1% | 40,092 | 0.0% | 2.36% | -3.6% | |
BRKB | BERKSHIRE HATHAWAY INC DELcl b | $875,000 | +8.3% | 4,773 | 0.0% | 0.98% | +6.7% | |
PCLN | New | PRICELINE GRP INC | $798,000 | – | 436 | +100.0% | 0.89% | – |
BIDU | BAIDU INCspon adr rep a | $743,000 | +38.4% | 3,000 | 0.0% | 0.83% | +36.1% | |
GOOGL | ALPHABET INCcap stk cl a | $503,000 | +4.6% | 517 | 0.0% | 0.56% | +2.9% | |
PX | PRAXAIR INC | $434,000 | +5.3% | 3,107 | 0.0% | 0.48% | +3.6% | |
BRKA | BERKSHIRE HATHAWAY INC DELcl a | $275,000 | +7.8% | 1 | 0.0% | 0.31% | +5.9% | |
MKL | New | MARKEL CORP | $246,000 | – | 230 | +100.0% | 0.28% | – |
VALEANT PHARMACEUTICALS INTL | $244,000 | -17.0% | 17,000 | 0.0% | 0.27% | -18.3% | ||
AMGN | New | AMGEN | $203,000 | – | 1,090 | +100.0% | 0.23% | – |
EPAM | Exit | EPAM SYS INC | $0 | – | -3,900 | -100.0% | -0.37% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MASTERCARD INC | 35 | Q3 2023 | 43.3% |
BERKSHIRE HATHAWAY INC DEL | 35 | Q3 2023 | 2.6% |
BERKSHIRE HATHAWAY INC DEL | 28 | Q3 2023 | 0.6% |
ALPHABET INC | 25 | Q3 2023 | 20.9% |
ALPHABET INC | 25 | Q3 2023 | 1.4% |
ADTALEM GLOBAL ED INC | 19 | Q3 2023 | 56.8% |
VALEANT PHARMACEUTICALS INTL | 19 | Q4 2017 | 30.1% |
DEVRY INC DEL | 16 | Q1 2017 | 58.4% |
META PLATFORMS INC | 16 | Q3 2023 | 11.7% |
PRAXAIR INC | 13 | Q4 2017 | 3.6% |
View FARLEY CAPITAL L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
LaPorte Bancorp, Inc. | February 14, 2014 | ? | ? |
Oconee Federal Financial Corp. | February 14, 2014 | ? | ? |
Sunshine Financial Inc | February 14, 2014 | ? | ? |
BSB Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
IF Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
Jacksonville Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
Poage Bankshares, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
SP Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
West End Indiana Bancshares, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
OBA Financial Services, Inc.Sold out | February 14, 2012 | 0 | 0.0% |
View FARLEY CAPITAL L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-08 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-11 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View FARLEY CAPITAL L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.